Compass Therapeutics (CMPX) Preferred Stock Liabilities (2018 - 2020)
Compass Therapeutics (CMPX) posted Preferred Stock Liabilities of $129.9 million for Q1 2020, little changed sequentially from $129.9 million in Q4 2019, and little changed YoY from $129.9 million in Q2 2019.
Compass Therapeutics (CMPX) Preferred Stock Liabilities (2018 - 2020) Analysis & Trends
Compass Therapeutics has reported Preferred Stock Liabilities for 3 years, with the latest figure at $129.9 million in Q1 2020.
- Quarterly Preferred Stock Liabilities changed 0.0% year-over-year to $129.9 million in Q1 2020, while the trailing twelve-month figure through Mar 2020 was $129.9 million (changed 0.0% YoY) and the FY2020 annual result came in at $129.9 million, changed 0.0% from the prior year.
- Preferred Stock Liabilities steadied at $129.9 million in Q1 2020 per CMPX's latest filing, from $129.9 million in the prior quarter.
- Over five years, Preferred Stock Liabilities peaked at $129.9 million in Q4 2018 and troughed at $129.9 million in Q4 2018.
- A 3-year average of $129.9 million and a median of $129.9 million in 2018 frame the typical range for Preferred Stock Liabilities.
- The widest YoY moves for Preferred Stock Liabilities: up 0.0% in 2019, down 0.0% in 2019.
- Over 3 years, Preferred Stock Liabilities stood at $129.9 million in 2018, then changed by 0.0% to $129.9 million in 2019, then changed by 0.0% to $129.9 million in 2020.
- According to Business Quant data, Preferred Stock Liabilities over the past three periods registered $129.9 million, $129.9 million, and $129.9 million for Q1 2020, Q4 2019, and Q3 2019 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Compass Therapeutics | 405.20 Mn | 405.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 129.87 Mn |
| Dec 31, 2019 | 129.87 Mn |
| Sep 30, 2019 | 129.87 Mn |
| Jun 30, 2019 | 129.87 Mn |
| Mar 31, 2019 | 129.87 Mn |
| Dec 31, 2018 | 129.87 Mn |